Patent · US Active

Nuclease systems for genetic engineering

US11447774B2 · kind B2 · utility

0Cited by

1References

17Claims

0Family size

Assignees

The Board of Trustees of the Leland Stanford Junior University · US
INTIMA BIOSCIENCE, INC. · US

Inventors

Lei S. Qi · Tianjin, CN
Modassir Choudhry · New York, US
Xueqiu Lin · San Bruno, US
Xiaoshu Xu · Santa Clarita, US

Key dates

Filing date	Mar 4, 2020
Grant date	Sep 20, 2022
Priority date	—
Expiry date	Mar 4, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/322
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Fusion constructs encoding RNase-H-like domain containing compositions are disclosed. Disclosed are also compositions and methods utilizing RNase-H-like domain containing compositions for the treatment of cancer. Also disclosed are the methods of making and using the RNase-H-like domain containing compositions in treating various diseases, conditions, and cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.